Deltec Asset Management LLC acquired a new position in shares of Semler Scientific, Inc. (NASDAQ:SMLR – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 45,600 shares of the company’s stock, valued at approximately $2,462,000.
Other institutional investors have also recently modified their holdings of the company. Quest Partners LLC grew its holdings in Semler Scientific by 48.0% during the 3rd quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after buying an additional 817 shares during the last quarter. US Bancorp DE boosted its stake in shares of Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after acquiring an additional 1,158 shares during the last quarter. Sanctuary Advisors LLC purchased a new stake in Semler Scientific during the 3rd quarter worth about $104,000. GSA Capital Partners LLP raised its stake in Semler Scientific by 73.9% in the 3rd quarter. GSA Capital Partners LLP now owns 10,336 shares of the company’s stock valued at $243,000 after purchasing an additional 4,393 shares during the last quarter. Finally, Verition Fund Management LLC purchased a new position in Semler Scientific in the 3rd quarter valued at about $251,000. 49.37% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, Lake Street Capital lifted their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a report on Friday, January 24th.
Semler Scientific Price Performance
Semler Scientific stock opened at $51.24 on Wednesday. Semler Scientific, Inc. has a 12 month low of $20.88 and a 12 month high of $81.56. The company has a market cap of $474.99 million, a price-to-earnings ratio of 25.00 and a beta of 1.17. The stock’s 50-day moving average is $59.74 and its 200-day moving average is $41.25.
Semler Scientific (NASDAQ:SMLR – Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%. The firm had revenue of $13.51 million for the quarter.
Semler Scientific Company Profile
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
Further Reading
- Five stocks we like better than Semler Scientific
- Where Do I Find 52-Week Highs and Lows?
- Market Volatility Creates Opportunity in These 3 Value Stocks
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Visa and Mastercard Remain Strong Plays as Consumers Keep Swiping
- Profitably Trade Stocks at 52-Week Highs
- 2 High-Yield Consumer Staples Stocks Ready to Deliver Big Returns
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (NASDAQ:SMLR – Free Report).
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.